|
COMPOSITION
Each actuation contains:
Chlorhexidine (INN) gluconate, 0,025 mg.; Benzocaine (INN), 0,75 mg.
Excipients: Saccharin sodium, 0,50 mg; Ethanol 96%º, 31,25 mg. Glycerol, Glycerine ammonium and Strawberry essence.
PHARMACEUTICAL FORM AND CONTENTS OF THE PACKAGE
Nebulizer bottle containing 25 ml. of solution.
ACTIVITY
Bucospray® (Chlorhexidine and Benzocaine) is a speciality that, in its formulation, combines the antiseptic activity of chlorhexidine with the local anaesthetic properties of benzocaine. While the antiseptic disinfects the bucco-pharyngeal area, the local anaesthesia relieves the pain.
INDICATIONS
Bucospray® (Chlorhexidine and Benzocaine) is indicated for the symptomatic relief of mild infections of the mouth and throat that cause pain, such as throat irritation, aphonia and small mouth ulcers.
CONTRAINDICATIONS
Bucospray® should not be administered to patients with hypersensitivity to any of its ingredients.
PRECAUTIONS
If the symptoms persist for more than two days or get worse or are accompanied by fever, headache, nausea or vomiting your doctor should be consulted as soon as possible.
This medication has local action; therefore when it is applied avoid swallowing or inhaling the medication.
INTERACTIONS
This medication should not be used by patients being treated with sulphonamides, nor with cholinesterase inhibitors. Do not use concomitantly with other bucco-pharyngeal antiseptics without consulting your doctor.
WARNINGS
Sportspersons are informed that this medication contains an ingredient which may give a positive result in a doping control test.
Since this medication contains the excipient ethanol, it can be a cause of risk in patients with hepatic disorders, alcoholism, epilepsy and in pregnant women and children.
Pregnancy and lactation
Important information for women
If you are pregnant or think you could be, consult your doctor before you start to take this medication. The administration of medications during pregnancy may be dangerous to the embryo or foetus and should be supervised by your doctor.
Women should consult their doctor before taking this medication when they are breastfeeding.
Use in children
This medication is contraindicated in children of less than 6 years of age.
Effects on ability to drive and use machines
Bucospray® is not known to impair the ability to drive or use machines.
POSOLOGY
Adults: Spray two doses every two or three hours, increase the time between each application as the discomfort decreases: Under no circumstances should more than sixteen doses be taken in any 24 hours period by adults.
Children aged 6 to 12 years: Spray one dose every two or three hours. Under no circumstances should more than eight doses be taken in any 24 hours period by children aged 6 to 12 years.
Patients should be cautioned not to eat or drink for at least 60 minutes after taking this medication.
INSTRUCTIONS FOR THE CORRECT ADMINISTRATION OF THE PREPARATION
Before you use this medication for the first time, it is convenient that you spray two or three doses into the air in order to fill the dispensing valve.
OVERDOSE
In the case of an overdose or accidental ingestion of excessive quantities nausea, vomiting, abdominal pain, dizziness, blurred vision, tremor, somnolence and paleness may occur.
If any of these occur go to your doctor and indicate the medication and amount taken or contact your local poison control centre.
ADVERSE EFFECTS
Irritative skin reactions to chlorhexidine preparations have been reported but disappear upon treatment discontinuation. Generalised allergic reactions to chlorhexidine, disturbance of taste sensation and discoloration of the teeth and silicate or composite restorations, gastrointestinal discomfort may occasionally occur. If you notice these or any other reactions not mentioned in this leaflet, please inform your doctor or pharmacist.
STORAGE
Store below 25°C.
EXPIRY
This medication should not be used after the expiry date indicated on the pack.
/ BUY BUCOSPRAY /
|
|
CONTACT INFORMATION
